What to expect from PEGS Europe 2023: Day 2
Drug Discovery World
NOVEMBER 9, 2023
Klaus Wagenbauer, PhD, Founder & CEO, Plectonic, on: ‘Programmable DNA-origami-based T cell engagers: PTE’. They will present on expression and characterisation of novel GCN-related N-acetyltransferases by Nucleras rapid protein assess system.
Let's personalize your content